Analysis of quality metrics in comprehensive cancer genomic profiling using a dual DNA

Analysis of quality metrics in comprehensive cancer genomic profiling using a dual DNA–RNA panel

Published:2024-03 Issue: Volume:39 Page:e00368
ISSN:2352-5517
Container-title:Practical Laboratory Medicine
language:en
Short-container-title:Practical Laboratory Medicine

Author:

Watanabe Kousuke^ORCID,Kohsaka Shinji,Tatsuno Kenji,Shinozaki-Ushiku Aya,Isago Hideaki,Kage Hidenori,Ushiku Tetsuo,Aburatani Hiroyuki,Mano Hiroyuki,Oda Katsutoshi

Funder

Sysmex Corporation

Japan Agency for Medical Research and Development

Publisher

Elsevier BV

Reference8 articles.

1. The Japanese Society of Pathology Practical Guidelines on the handling of pathological tissue samples for cancer genomic medicine;Hatanaka;Pathol. Int.,2021

2. Comprehensive screening of target molecules by next-generation sequencing in patients with malignant solid tumors: guiding entry into phase I clinical trials;Tanabe;Mol. Cancer,2016

3. Clinical utility of Todai OncoPanel in the setting of approved comprehensive cancer genomic profiling tests in Japan;Kage;Cancer Sci.,2023

4. Comprehensive assay for the molecular profiling of cancer by target enrichment from formalin-fixed paraffin-embedded specimens;Kohsaka;Cancer Sci.,2019

5. Comparison of pre-analytical FFPE sample preparation methods and their impact on massively parallel sequencing in routine diagnostics;Heydt;PLoS One,2014

Cited by 1 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hybrid-feature based spherical quasi-conformal registration for AD-induced hippocampal surface morphological changes;Computer Methods and Programs in Biomedicine;2024-11